VALERIE PACHUTA: Open Payments
NPI 1952684748 · GENESEO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 21 payments from 10 companies in 2025. Trend: 2023 $752 · 2024 $591 · 2025 $697
Food & beverage: $625Education: $72
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $170 |
| Janssen Biotech, Inc. | 3 | $128 |
| UCB, Inc. | 5 | $114 |
| Organon LLC | 1 | $92 |
| ABBVIE INC. | 4 | $72 |
| GENZYME CORPORATION | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, VTAMA, SKYRIZI, DUPIXENT, Sotyktu, OPZELURA.
Industry payments across NY — which companies pay providers there.
